Interestingly, some TLO in prostate tumors from patients with advanced disease contained many PCNA+CD20+ B cells (Figure 3C) and large CD21+ FDC networks (Figure 3G), indicating that despite the suppressive environment, activated B cells were still able to induce the differentiation of tumor-associated stromal cells into FDC. This evidence concerns the gene CR2 and prostate neoplasm.